#tirzepatide
6 stories
The risky boom in cut-price weight-loss drugs
Compounding pharmacies are flooding the market with cheaper versions of GLP-1 drugs, but with far less oversight than brand-name alternatives.
TIME · 3m
Sorority Rush Gets Ozempic Makeover
College women use weight-loss injections to compete in sorority rush.
Fox News · 2m
Mounjaro Muscle Loss Guide
How to keep muscle while losing weight with Mounjaro.
Wellbeing Magazine · 1m
Eli Lilly Q2 2026 Revenue Surge
Lilly's Mounjaro revenue nearly doubled to $9.94 billion in Q2 2026, driving 48% revenue growth.
Alphastreet - Earnings Decoded. Market Intelligence Delivered · 1m
Eli Lilly's obesity bet hinges on September 30 data
A two-drug combo could justify Lilly's trillion-dollar valuation, but the mid-stage trial results will determine if it's a breakthrough or an expensive gamble.
24/7 Wall St. · 1m
Medical weight loss beats DIY dieting
Supervised programs address the biological systems that sabotage self-directed weight loss efforts.
Wellbeing Magazine · 2m